Volcano, manufacturer of intravascular ultrasound and related products used to diagnose heart disease, announced the terms for its IPO on Wednesday. The Rancho Cordova, CA based company plans to offer 6.8 million shares at a range of $10-12 and has a proposed market cap of $351 million. Lead manager JP Morgan has yet to announce a pricing date for this deal.
